Abstract:OBJECTIVE:Acute monocytic leukemia (AML)-M5 is the common type of acute myeloid leukemias in children. Studies have shown that there are abundant lipopolysaccharide (LPS) receptor (designated as CD14) molecules on the cell membrane of M5 cells and they play an important role in the diagnosis of M5, since they can be recognized and bound by mouse-anti-human CD14 monoclonal antibody (McAb). However, mouse-originated antibodies are largely not suitable for clinical application due to the severe side effects, thus "humanized antibody" is desired. As the first step for developing humanized antibody, the construction and expression of single chain antibody (scFv) with functional protein are necessary. The present study aimed to express ZCH-7-2F9 ScFv (scFv(2F9)) in eukaryotic cells and obtain the scFv(2F9) protein with a high biological activity.METHODS:Four primers were synthesized to construct the eukaryotic expressional vector, which included SfiI and EcoRI enzyme cleaving site, 6 x His and stop code TGA sequences. scFv(2F9) gene was amplified through splicing by overlap extension (SOE) using the high fidelity Taq polymerase. Positive recombinants (pSectag2A/scFv(2F9)) were identified through enzyme cleaving and sequenced before expression and were transformed into Chinese hamster ovary (CHO) cells for expression. Western-Blot and flow cytometry (FCM) were carried out to determine the relative molecular mass (Mr) and binding activity of scFv(2F9).RESULTS:The cloned scFv(2F9) gene was identified to be functional by sequencing and expressing. The interested protein could be detected in the culture supernatant of transformed CHO cells with an Mr of 31 000. The blocking test showed that the positive cell percentages, the mean fluorescence intensity (MFI) and the peak of channel (peak Ch) were reduced by 90.02%, 63.30% and 63.38%, respectively after blocking with scFv(2F9), while those were 4.55%, 10.09% and 5.02% after blockage using the supernatant from the CHO cells transfected with blanked vector pSectag2A.CONCLUSIONS:The scFv(2F9) against human CD14 antigen was successfully expressed in eukaryotic cells and showed a high biological activity, which may be useful for the further studies on its humanized antibodies.

[Preparation and Characterization of a Monoclonal Antibody Against Human C-Kit].

Preparation and characterization of a novel monoclonal antibody against human PD-1

[Preparation and Characterization of Monoclonal Antibody Against Human Telomeric Repeat Binding Factor 1].

Generation and Characterization of Four Novel Monoclonal Antibodies Against Human Programmed Death-1 Molecule.

Preparing Monoclone Antibody of Human Thymidine Kinase

[Eukaryotic Expression and Determination of ZCH-7-2F9 Single Chain Antibody Against Human CD14].

Preparation and preliminary characterization of rabbit monoclonal antibodies against human midkine

Preparation and characterization of monoclonal antibodies against human cytokeratin 19 fragment antigen 21-1

Development of a Monoclonal-Based Ic-Elisa for the Determination of Kitasamycin in Animal Tissues and Simulation Studying Its Molecular Recognition Mechanism.

[Preparation and Identification of Monoclonal Antibodies Against Chicken Cell Cycle Checkpoint Kinase 2 (Cchk2)].

Preparation of monoclonal antibody against human tissue kallikrein and development of an ELISA kit

Generation and Characterization of Monoclonal Antibody Against Human PIK3IP1

Preparation, Characterization and Application of Anti-HCCR Monoclonal Antibody

Preparation of a functional monoclonal antibody against human 4-1BBL molecule and analysis of its biological characteristics

Characterization of a Fusion Protein Composed of the Extracellular Domain of c-kit and the Fc Region of Human IgG Expressed in a Baculovirus System

Preparation and Characterization of A Monoclonal Antibody Against Cklf1 Using Dna Immunization with in Vivo Electroporation

Preparation of Anti-Human 4-1BB Monoclonal Antibody and Analysis of Its Biological Functions

[Preparation and Characterization of a Novel Functional Anti-Human CD83 Monoclonal Antibody].

[Development and Application of CK-MB Specific Monoclonal Antibodies].

[Preparation, Purification and Characterization of the Polyclonal Antibody Against Human CMTM4].

Preparation of a Monoclonal Antibody Against Human 41Gb7-H3 Molecule and Analysis of Its Biological Characteristics